key: cord-0320503-682g5jqm
authors: Porte, Rémi; Silva-Gomes, Rita; Theroude, Charlotte; Parente, Raffaella; Asgari, Fatemeh; Sironi, Marina; Pasqualini, Fabio; Valentino, Sonia; Asselta, Rosanna; Recordati, Camilla; Doni, Andrea; Inforzato, Antonio; Rodriguez-Gallego, Carlos; Obando, Ignacio; Colino, Elena; Bottazzi, Barbara; Mantovani, Alberto
title: Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3
date: 2022-04-14
journal: bioRxiv
DOI: 10.1101/2022.04.14.488329
sha: 9101ab39340c5d41d055758cf61a6a556d9db8ba
doc_id: 320503
cord_uid: 682g5jqm

Streptococcus pneumoniae is a major pathogen in children, elderly subjects and immunodeficient patients. PTX3 is a fluid phase pattern recognition molecule (PRM) involved in resistance to selected microbial agents and in regulation of inflammation. The present study was designed to assess the role of PTX3 in invasive pneumococcal infection. In a murine model of invasive pneumococcal infection, PTX3 was strongly induced in non-hematopoietic (particularly, endothelial) cells. The IL-1β/MyD88 axis played a major role in regulation of the Ptx3 gene expression. Ptx3-/- mice were more susceptible to invasive pneumococcal infection. Although high concentrations of PTX3 had opsonic activity in vitro, no evidence of PTX3-enhanced phagocytosis was obtained in vivo. In contrast, Ptx3-deficient mice showed enhanced recruitment of neutrophils and inflammation. Using P-selectin deficient mice, we found that protection against pneumococcus was dependent upon PTX3-mediated regulation of neutrophil inflammation. In humans, PTX3 genetic polymorphisms were associated with invasive pneumococcal infections. Thus, this fluid phase PRM plays an important role in tuning inflammation and resistance against invasive pneumococcal infection.

Streptococcus pneumoniae (or pneumococcus) is a major leading cause of bacterial 49 pneumonia, meningitis and sepsis in children, elders and immunodeficient patients. This 50 pathogen is estimated to be responsible for most of the lower respiratory infections, causing 51 around 1.18 million deaths annually worldwide (Troeger et al., 2018) . Despite the widespread 52 use of pneumococcal conjugate vaccines and antibiotic treatments, the combination of high 53 carriage rate, ability to become pathogenic to the host, and genetic adaptability, make 54 pneumococcus a significant cause of community-and hospital-acquired infections (Weiser et observed that PTX3 genetic deficiency is associated with higher susceptibility to infection and 97 upregulated mainly in the lung, aorta and heart, while other organs like brain, kidneys and 122 liver did not show higher Ptx3 expression compared to the uninfected mice (Figure S1D It has been previously reported that neutrophils contain preformed PTX3, representing 164 an important source of the protein, rapidly released in response to proinflammatory cytokines 165 or microbial recognition (Jaillon et al., 2007) . In agreement, we observed that human 166 neutrophils can release PTX3 upon stimulation with S. pneumoniae ( Figure S2A ). To 167 investigate the involvement of neutrophils in the production of PTX3 in our model, we used 168 mice lacking granulocyte colony-stimulating factor receptor (Csf3r -/-). These Since PTX3 can be produced by hematopoietic and non-hematopoietic cells, bone 178 marrow chimeras were used to evaluate the cellular compartment responsible for PTX3 179 production. During pneumococcal infection, we did not observe any difference in the levels of 180 PTX3 in the respiratory tract and in the serum of WT mice receiving bone marrow from Ptx3 -181 /or WT animals, while no PTX3 was measured in Ptx3 -/mice receiving WT or Ptx3 -/bone 182 Systemic administration of recombinant PTX3 to Ptx3 -/mice rescues the phenotype. 227

As reported in Figure 4D , PTX3 administration in Ptx3 -/mice reduced lung colonization to 228 the same level observed in WT mice. We then evaluated the antibacterial activity of PTX3 on 229 S. pneumoniae serotype 3. WT animals were treated locally with 1µg of recombinant protein 230 before infection or 12h post-infection. Under both conditions we observed a significant 231 reduction (44% and 57% respectively; P<0.01) of the pulmonary bacterial load compared 232 with the CFU found in mice treated with vehicle alone ( Figure 4E ). In an effort to explore the mechanism responsible for PTX3-mediated resistance, we 255 first assessed the effect of the recombinant protein on the in-vitro growth of S. pneumoniae. 256

The incubation of S. pneumoniae with 25-250 µg/ml of recombinant PTX3 did not have any 257 effect on the growth rate of the bacteria ( Figure S4) . opsonic activity, we first analyzed PTX3 binding to S. pneumoniae. By using a flow 262 cytometry assay, we analyzed PTX3 binding to S. pneumoniae serotype 3 mimicking the 263 bacteria/PTX3 ratio found in the infected lung (10 6 CFU/100 ng PTX3). Under these 264 conditions, we did not observe any interaction of PTX3 with bacteria and, even with an 265 amount of PTX3 5-to 10-fold higher than the one produced in the entire lung, less than 1% of 266 the bacteria were bound (Figure 5A ). At 500 µg/ml of PTX3 (5000-fold higher than in the 267 lung homogenates) we observed binding to only 36.4% of bacteria ( Figure 5A ). 268

We then assessed phagocytosis in vitro and in vivo using GFP-expressing 269 S. pneumoniae serotype 1 (S. pneumoniae-GFP). In a first set of experiments, human 270 neutrophils were incubated with PTX3-opsonized S. pneumoniae-GFP. We confirmed that 271 PTX3 exerts opsonic effects, increasing the phagocytosis of pneumococcus by neutrophils, 272 but only at very high concentrations, i.e. higher than 100 µg/ml ( Figure 5B ). We then moved 273 to an in vivo setting. Since the instillation of as low as 1µg of PTX3 was sufficient to induce 274 an antibacterial effect when administrated locally just before the infection ( Figure 4E presented also an increased vascular damage score based on higher perivascular edema and 336 hemorrhages ( Figure S5E ). Flow cytometry analysis revealed that the higher inflammation in 337

Ptx3 deficient mice was due to a significant increase of neutrophil recruitment in the BAL and 338 the lung ( Figure 6D ). Moreover, we did not observe any change in the recruitment of other 339 myeloid cells, i.e. macrophages, eosinophils and monocytes. This phenotype was also 340 observed with the serotype 1 model of invasive pneumococcal infection ( Figure S5F ). 341

Finally, we observed that intranasal treatment with recombinant PTX3 was also 342 associated with a decrease in the neutrophil number in BAL and lungs, demonstrating that 343 PTX3 has a direct role in the control of neutrophil migration in the respiratory tract ( and Ptx3 deficient mice, uninfected or infected with pneumococcus ( Figure S6E ). Therefore, 395

we investigated whether interaction with P-selectin could be relevant in the regulation of 396 neutrophil recruitment into the lung. We investigated the ability of PTX3 to dampen 397 neutrophil transmigration through endothelial cell layer in vitro, using S. pneumoniae as the 398 attractive signal. We observed that PTX3 could block 40% of the neutrophil migration 399 induced by S. pneumoniae ( Figure 7C ). Moreover, treatment of endothelial cells with anti-400 CD62P (P-selectin) antibody induced the same blocking effect. We did not observe any 401 additional blocking effect of PTX3 in association with anti-CD62P, suggesting that PTX3 402 exerts its blocking effect through P-selectin. To confirm that PTX3 protects infected mice by 403 blocking P-selectin, we used P-selectin deficient mice (Selp -/-). In Selp -/mice PTX3 treatment 404 did not reduce the bacterial load ( Figure 7D ). Moreover, we treated WT and Similar frequencies were observed for the +734A allele in patients and controls 454 (67.54% and 61.58%, respectively, P=0.213, Table 1 ). However, when the haplotypes 455 determined by the three SNPs (rs2305619, rs3816527, rs1840680) were examined, we found 456 that the AAA haplotype was twice as frequent in IPD patients as in healthy controls (9.67% 457 and 4.26% respectively, P=0.0102, Table 2 ). This association was even stronger when 458 considering two SNPs only (+281A and +734A), including the one associated with lower 459 levels of the protein (11.4% and 4.94% respectively, P=0.0044, Table 2 ). These observations 460 suggest that also in humans PTX3 could play a role in the control of S. pneumoniae infection. 461 462 

To assess whether the +734A/C polymorphism in the coding region of the human 465 invasive pneumococcus infection (Nathan, 2006) . In contrast with our results, a recent paper 589 reported a proinflammatory role of PTX3 in the context of serotype 2 S. pneumoniae infection 590 (Koh et al., 2017) . However, when we used D39 serotype 2 pneumococcus in our setting and 591 with our mice, we were not able to find any difference between WT and Ptx3 -/pneumococcal 592 induced inflammatory responses, suggesting that other factors, including housing conditions, 593 could have impact on the phenotype. 594 

All mice used in this study were on a C57BL/6J genetic background. PTX3-deficient mice 610

were generated as described in (Garlanda et al., 2002) . Ptx3 -/and P-selectin (Selp -/-) double 611 deficient mice were generated as described in (Doni et al., 2015) . Csf3r -/mice were generated Each S. pneumoniae strain (serotype 1 ST304 and serotype 3 ATCC6303) was cultured and 630 stored as previously described (Porte et al., 2015) . Briefly, Todd-Hewitt yeast broth (THYB) 631 (Sigma-Aldrich) was inoculated with fresh colonies grown in blood agar plates and incubated 632 at 37°C until an optical density at 600 nm (OD 600 ) of 0.7 to 0.9 units was reached. Cultures 633

were stored at -80°C in THYB with 12% glycerol for up to 3 months. GFP-expressing 634 serotype 1 was constructed as described previously (Kjos et al., 2015) . Clinical isolate E1586 635 serotype 1 S. pneumoniae was grown at 37°C in THYE until an OD 600 of 0.1, then 100 ng/ml 636 of synthetic competence-stimulating peptide 1 (CSP-1; Eurogentec) was added for 12min at 637 37°C to activate transformation machinery. P hlpA -hlpA-gfp_Cam r DNA fragment provided by (or focal), mild (or multifocal, <10% of blood vessels), moderate (or multifocal, 10-50% of 737 blood vessels) and marked (or multifocal, >50% of blood vessels), respectively. 738 739

The binding of PTX3 on S. pneumoniae was assessed as described previously (Bottazzi et al., 741 2015) . Briefly, 10 6 CFU S. pneumoniae were washed in PBS +/+ and suspend with 10 µg/ml, 742 50 µg/ml or 500 µg/ml of biotinylated recombinant PTX3 for 40min at room temperature. 743

Bacteria were washed with PBS +/+ and stained with streptavidin-Alexa Fluor 647 (4 µg/ml, 744

Invitrogen) for 30min at 4°C. Washed bacteria were then fixed with 4% formalin for 15min at 745 4°C. Bacteria were then read by flow cytometry using FACSCanto II (BD Bioscience). 746

Unstained S. pneumoniae were used as negative control. antibody panel able to distinguish macrophages (CD45 + , CD11b -, SiglecF + ), neutrophils 837 (CD45 + , CD11b + , SiglecF -, Ly6C + , Ly6G + ), monocytes (CD45 + , CD11b + , SiglecF -, 838

Ly6C low/moderate/high , Ly6G -) and eosinophils (CD45 + , CD11b + , SiglecF + ) as described in Figure As for SNP association analyses, these were performed using the PLINK v1.07 program 871 (Purcell et al., 2007) . All polymorphisms had a call rate of 100%, and were tested for Hardy-872

Weinberg equilibrium (HWE) in controls before inclusion in the analyses (P-HWE >0.05). In 873 detail, deviations from HWE were tested using the exact test (Wigginton et al., 2005 ) 874 implemented in the PLINK software. For each SNP, a standard case-control analysis using 875 allelic chi-square test was used to provide asymptotic P values, odds ratio (OR), and 95% 876 confidence interval (CI), always referring to the minor allele. Haplotype analysis and phasing 877 was performed considering either all three SNPs together or by using the sliding-window 878 option offered by PLINK. All P values are presented as not corrected; however, in the 879 relevant tables, Bonferroni-corrected thresholds for significance are indicated in the footnote. 

Role of Streptococcus pneumoniae Proteins in Evasion of 899

Interaction of C1q With Pentraxin 3 and IgM Revisited: Mutational 903 Studies With Recombinant C1q Variants

908 Influence of Pentraxin 3 (PTX3) Genetic Variants on Myocardial Infarction Risk 909 and PTX3 Plasma Levels

Serum Levels in Patients with Ventilator-Associated Pneumonia: A Nested 914 Case-Control Study

Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and 919 fibrinogen induced platelets aggregation

Pentraxin 3 deficiency protects 925 from the metabolic inflammation associated to diet-induced obesity

An Integrated View of Humoral 928 Innate Immunity: Pentraxins as a Paradigm

Recognition of Neisseria meningitidis by the Long 933

Its Role as an Endogenous Adjuvant

Multimer Formation and Ligand Recognition by 938 the Long Pentraxin PTX3

Extracellular Adenosine Protects against Streptococcus 942 pneumoniae Lung Infection by Regulating Pulmonary Neutrophil Recruitment

Pentraxin-3 polymorphisms and invasive mold infections in 946 acute leukemia patients receiving intensive chemotherapy

PTX3 Polymorphisms Influence Cytomegalovirus 951 Reactivation After Stem-Cell Transplantation

PTX3 genetic 955 variations affect the risk of Pseudomonas aeruginosa airway colonization in 956 cystic fibrosis patients

Genetic PTX3 Deficiency and 961 Aspergillosis in Stem-Cell Transplantation

PTX3-965 Based Genetic Testing for Risk of Aspergillosis After Lung Transplant: Table 966

The Proteomic Profile of 969 Circulating Pentraxin 3 (PTX3) Complex in Sepsis Demonstrates the 970 Interaction with Azurocidin 1 and Other Components of Neutrophil 971 Extracellular Traps

Btk inhibitor ibrutinib reduces inflammatory myeloid cell 975 responses in the lung during murine pneumococcal pneumonia

Regulation of leukocyte recruitment by the 981 long pentraxin PTX3

An acidic microenvironment sets 986 the humoral pattern recognition molecule PTX3 in a tissue repair mode

G*Power 3: a flexible statistical 989 power analysis program for the social, behavioral, and biomedical sciences

Should MASP-2 Deficiency Be 995 Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway

PTX3, a Humoral 998 Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer

Non-1003 redundant role of the long pentraxin PTX3 in anti-fungal innate immune 1004 response

Regulation of the Complement System by Pentraxins

Phagocyte 1008 responses towards Aspergillus fumigatus

Pentraxin 3 Gene Polymorphisms 1011 and Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease 1012 Patients

Triggering receptor expressed on myeloid cells-1015 1 (TREM-1) improves host defence in pneumococcal pneumonia

Structural 1020 characterization of PTX3 disulfide bond network and its multimeric status in 1021 cumulus matrix organization

The Humoral Pattern Recognition Molecule PTX3 Is a Key Component 1027 of Innate Immunity against Urinary Tract Infection

The humoral pattern recognition receptor PTX3 is stored in neutrophil 1032 granules and localizes in extracellular traps

Plasma long pentraxin 3 (PTX3) concentration is a novel 1036 marker of disease activity in patients with community-acquired pneumonia

Bright Fluorescent Streptococcus pneumoniae for Live-Cell 1040 Imaging of Host-Pathogen Interactions

Long 1043 pentraxin PTX3 mediates acute inflammatory responses against 1044 pneumococcal infection

Calculating and reporting effect sizes to facilitate cumulative 1047 science: a practical primer for t-tests and ANOVAs

1051 Endogenous and exogenous pentraxin-3 limits postischemic acute and 1052 chronic kidney injury

Impaired Production 1055 and Increased Apoptosis of Neutrophils in Granulocyte Colony-Stimulating 1056 Factor Receptor-Deficient Mice

Mechanisms of phagocytosis and host 1059 clearance of Pseudomonas aeruginosa

Transendothelial Neutrophil Migration in the Lung, Liver, Kidney, and Aorta

1066 Production of Interleukin-20 cytokines limits bacterial clearance and lung 1067 inflammation during infection by Streptococcus pneumoniae

Alveolar pentraxin 3 as an early marker of microbiologically confirmed 1072 pneumonia: a threshold-finding prospective observational study

Role of complement and Fc{gamma} receptors in the 1076 protective activity of the long pentraxin PTX3 against Aspergillus fumigatus

The 1080 Therapeutic Potential of the Humoral Pattern Recognition Molecule PTX3 in 1081 Chronic Lung Infection Caused by Pseudomonas aeruginosa

Neutrophils and immunity: challenges and opportunities

DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene 1088 variants associate with pulmonary tuberculosis risk in West Africans

Neutrophils Driving

Unconventional T Cells Mediate Resistance against Murine Sarcomas and 1095 Selected Human Tumors

The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional 1099 Player and Biomarker of Infections and Sepsis

Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and 1104 Influenza Virus-Associated Pneumococcal Mouse Infections

PLINK: A Tool Set for 1108 Whole-Genome Association and Population-Based Linkage Analyses. The 1109

2020. Neutrophil: Methods and Protocols, Methods in 1111 Molecular Biology

Dynamics of Lung Defense in Pneumonia: 1114 Resistance, Resilience, and Remodeling

Host-response biomarkers 1117 for the diagnosis of bacterial respiratory tract infections

1120 van 't Veer C, van der Poll T. 2014. The endothelial protein C receptor impairs 1121 the antibacterial response in murine pneumococcal pneumonia and sepsis

Urinary tract infection: recent insight into the 1124 evolutionary arms race between uropathogenic Escherichia coli and our 1125 immune system

Capillary leakage provides nutrients and 1130 antioxidants for rapid pneumococcal proliferation in influenza-infected lower 1131 airways

1134 Investigation of the clinical significance of detecting PTX3 for community-1135 acquired pneumonia

Inflammatory 1139 biomarkers are associated with aetiology and predict outcomes in community-1140 acquired pneumonia: results of a 5-year follow-up cohort study

Role of Inflammatory 1143 Risk Factors in the Pathogenesis of Streptococcus pneumoniae. Front 1144 Immunol

Recognition and inhibition of SARS-CoV-2 1150 by humoral innate immunity pattern recognition molecules

The antimicrobial activity of C-reactive protein

Inhibition of 1156 Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces 1157 Inflammation and Lung Injury in Mice

Investigating the role of pentraxin 3 as a biomarker for bacterial infection 1161 in subjects with

Serotype evolution in Western Europe: perspectives on invasive 1165 pneumococcal diseases (IPD)

Estimates of the global, regional, and national morbidity, 1191 mortality, and aetiologies of lower respiratory infections in 195 countries

Association of Serotype with Risk of Death Due to 1198 Pneumococcal Pneumonia: A Meta-Analysis

Streptococcus pneumoniae: transmission, 1201 colonization and invasion

A Note on Exact Tests of Hardy-1204

PTX3 Polymorphisms and Invasive Mold 1209 Infections After Solid Organ Transplant: Figure 1

spleen is 5 CFU represented by a dotted line. Statistical significance was determined using the 1226

test comparing results to uninfected mice (*P<0.05 and **P<0.01)

Cellular sources of PTX3 after stimulation with S. pneumoniae. 1229 (A) PTX3 protein levels, measured by ELISA

neutrophils/100µl stimulated for 6h at 37°C with 10 7 CFU/ml of S. pneumoniae serotype 3 or 1231

ng/ml of phorbol myristate acetate (PMA). (B) MPO and PTX3 protein levels determined 1232 by ELISA in lung homogenates collected 36h post intranasal infection of WT and Csfr3 -/-1233 mice with 5x10 4 CFU of S

Relative Ptx3 mRNA expression determined by Real-Time quantitative PCR in human 1235 and murine endothelial cells after 6h stimulation with 10 6 CFU S. pneumoniae, 20 ng/ml IL-1236 1β or 100 ng/ml LPS (n=3-6). Results are reported as mean ± SEM. Statistical significance 1237 was determined using the non-parametric Krukal-Wallis test with post-hoc

Infection with S. pneumoniae serotype 1 and bacterial growth rate in the 1242 presence of PTX3

Mice were infected intranasally with 5x10 4 CFU of S. pneumoniae serotype 3 (A) or with 10 6

pneumoniae serotype 1 (B-E) and sacrificed at the indicated time points for tissue 1245 collection. (A) WT and Ptx3 -/-mice were infected with 5x10 4 CFU and bacterial load in lung 1246 was analyzed at 18h post-infection (data pooled from 2 independent experiments

PTX3 protein levels determined by ELISA in lung homogenates and serum collected at 1248 the indicated time points (n=4-5). (C) Correlation between PTX3 and IL-1β protein levels in 1249 lung homogenates of all infected mice sacrificed from 18 to 24 hours post-infection (n=8)

Results are reported 1252 as the mean ± SEM (B). CFU detection limits in the spleen is 5 CFU represented by a dotted 1253 line. Statistical significance was determined using the non-parametric Krukal-Wallis test with 1254 post-hoc

Lack of effect of PTX3 on S. pneumoniae growth rate

Growth rate of S. pneumoniae serotype 3 non-opsonized or pre-opsonized with recombinant 1259

PTX3 (25-250 µg/ml for 40 min) was measured in the culture condition

Material & Methods section. Absorbance (600 nm) was measured at the indicated time points 1261 (n=3) and is reported as mean ± SEM

Neutrophil recruitment during invasive pneumococcus infection

Mice were infected intranasally with 5x10 4 CFU of S. pneumoniae serotype 3 (A-E) or with 1265 10 6 CFU of serotype 1 (F) and sacrificed at the indicated time points for tissue collection

H&E) staining of formalin-fixed lung sections from WT mice 1267 uninfected and 36h after infection at 10x magnification. (B) MPO levels determined by 1268

C-D) Neutrophil 1269 number determined by flow cytometry in the BAL (C) and lung (D) collected at the indicated 1270 time points from WT mice (n=4-8). (E) Vascular damage histological score measured in lungs 1271 collected 18h post-infection from WT and Ptx3 -/-mice

Methods section) were determined on three H&E stained lung sections per mice at different 1273 depth separated by at least 100µm each (n=6-10). (F) Neutrophil number determined by flow 1274 cytometry in the BAL and lung collected 18h post-infection from WT and Ptx3 -/-mice (data 1275 pooled from 2 independent experiments

Statistical significance was determined using the Mann-Whitney test comparing results to 1277 uninfected mice (*P<0.05, **P<0.01 and ***P<0.001)

PTX3 modulates neutrophil recruitment

A-B) Neutrophil number determined by 1283 flow cytometry in the lung (A) and BAL (B) collected 18h post-infection from WT and Ptx3 -/-1284 mice treated intraperitoneally 12h post-infection with 200µg/100µl of anti-Ly6G or isotype 1285 control antibodies (data pooled from 2 independent experiments, n=9-12). (C) Chemokines 1286 (CXCL1/CXCL2) and anaphylatoxins (C3a/C5a) levels measured by ELISA in lung 1287 homogenates collected 18h post-infection from WT and Ptx3 -/-mice (data pooled from 2 1288 independent experiments, n=20). (D) C3d level in lung homogenates collected 36h post-1289 infection from WT and Ptx3 -/-(KO) mice

S. pneumoniae respiratory infection. WT and Ptx3 -/-mice were infected intranasally with 1292

Uninfected mice were also collected for steady state expression. P-selectin 1294 expression was evaluated in lung homogenates by ELISA

WT and Ptx3 -/-mice treated intraperitoneally 12h post-infection with 50µg/100µl of anti-1297

Results are reported as mean ± SEM. Statistical 1298 significance was determined using the non-parametric Krukal-Wallis test with